Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids

Part of paid clinical trials in Los Angeles, California.

Sponsor
InSightec
Study ID
NCT05386615
Status
Recruiting
Apply to this trial

Conditions

  • Uterine Fibroid

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 50 Years
Healthy Volunteers
Not accepted

Interventions

  • Body System - Functional — DEVICE
    MR-Guided Focused Ultrasound

Study Details

The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.

Key Dates

Start date
Feb 16, 2016
Status verified
Apr 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Exablate
    Observational study of Exablate treatment.

Primary Outcome Measure

Occurrence of adverse events [ Time Frame: Through study completion, an average of 2 years. ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
UCLALos AngelesCalifornia90095
Polly Kay, RN, CCRP
[email protected]
310-794-0376
Steve Raman, MD (PRINCIPAL_INVESTIGATOR)
Stanford UniversityStanfordCalifornia94305
Caroline Huang
[email protected]
650-725-6409
Pejman Ghanouni, MD, PhD (PRINCIPAL_INVESTIGATOR)
Mayo ClinicRochesterMinnesota55905
Brittany Yaklich
[email protected]
507-538-7765
Gina Hesley, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

By research site
UCLA· Los Angeles, CAStanford University· Stanford, CAMayo Clinic· Rochester, MN

Related Studies